XWELL, Inc. (XWEL)
1.58
+0.06
(+3.95%)
USD |
NASDAQ |
Mar 13, 16:00
1.56
-0.02
(-1.27%)
After-Hours: 20:00
XWELL EPS Diluted (Quarterly) : -0.2557 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| FONAR Corp. | 0.3058 |
| Interpace Biosciences, Inc. | 0.0329 |
| Thermo Fisher Scientific, Inc. | 5.210 |
| Hypha Labs, Inc. | -0.0034 |
| Veracyte, Inc. | 0.5056 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.211M |
| Revenue (Quarterly) | 7.345M |
| Total Expenses (Quarterly) | 8.069M |
| Enterprise Value | 24.18M |
| Gross Profit Margin (Quarterly) | 17.32% |
| Profit Margin (Quarterly) | -2.87% |
| Earnings Yield | -199.9% |
| Normalized Earnings Yield | -195.77 |